Danish pharma major Novo Nordisk has announced the appointment of Sebnem Avsar Tuna as the new general manager (GM) of its UK ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

US biotech Regeneron Pharmaceuticals says that its investigational gene therapy DB-OTO showed clinically-meaningful hearing ...

Regeneron's DB-OTO gene therapy shows improved hearing in 10 of 11 children in the CHORD trial, with three reaching ...

Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...